Pathways - manually collected, often from reviews:
OpenBEL Selventa BEL large corpus:
DAB2
→
PRKCD
(directlyIncreases, DAB2 Activity)
Tseng et al., J Biol Chem 1999* Evidence: DOC-2/DAB2, a novel phosphoprotein with signal-transducing capability, inhibits human prostatic cancer cells (Tseng, C.-P., Ely, B. D., Li, Y., Pong, R.-C., and Hsieh, J.-T. (1998) Endocrinology 139, 3542-3553). However, its mechanism of action is not understood completely. This study delineates the functional significance of DOC-2/DAB2 protein phosphorylation and demonstrates that in vivo activation of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) induces DOC-2/DAB2 phosp...
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *